£5.9M
Parkwalk Advisors backed the round to help scale the federated data platform across global healthcare systems.
"Clinical research is broken by data silos,"
Parkwalk Advisors + 4 others
P
PACE
GovernmentPACE is an initiative focused on early-stage antimicrobial drug and diagnostic discovery.
Portfolio
3
companies
By category
- AI/ML£10.3M
By location
- London£9.3M
- United Kingdom£1.0M
Portfolio companies
Bitfount
Federated AI platform enabling secure clinical research collaboration without data sharing.
CT
Centauri Therapeutics
Centauri Therapeutics develops novel immunotherapies to target multidrug-resistant Gram-negative bacteria.
C
Clearly
Clearly provides artificial intelligence driven climate intelligence for fleet and logistics operators.
Team
MS
Marius Swart
Partner
BI
Beverley Isherwood
Programme Director
Recent investments
£1.0M
Centauri Therapeutics has secured £1m from PACE to develop its Alphamer technology targeting drug-resistant bacterial strains.
"We are pleased that Centauri’s project was selected to be funded in the first round of projects under PACE, in recognition of the value of this novel immunotherapeutic technology"
£3.4M
The seed round was co-led by Pace Ventures and Nine Realms to support product enhancement and team expansion.
"Decarbonising supply chains is not a new challenge, but one of the largest hurdles for businesses has been accessing and analysing comprehensive data, as a direct result of supply chain complexities and the nature in which this data has been collected up until now. We saw that by using our unique approach to collect, normalise and blend supply chain data, we could improve its interoperability and use it to provide actionable insights on transportation emissions down to the level of individual trips and packages."